Listed

Whitehawk Therapeutics, Inc.

WHWKNasdaqCIK 1422142HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q2 FY2026
Operating income−$18.1m, Q2 FY2026
Net income−$16.6m, Q2 FY2026
Whitehawk Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m6.0Revenue, Q3 FY2023, three months to 2023-09-30$6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure6.3Revenue, Q4 FY2023, three months to 2023-12-31$6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure5.4Revenue, Q1 FY2024, three months to 2024-03-31$5.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure6.2Revenue, Q2 FY2024, three months to 2024-06-30$6.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure7.2Revenue, Q3 FY2024, three months to 2024-09-30$7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure7.2Revenue, Q4 FY2024, three months to 2024-12-31$7.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure7.1Revenue, Q1 FY2025, three months to 2025-03-31$7.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure0.0Revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure0.0Revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure0.0Revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Cost of revenue$m0.7Cost of revenue, Q3 FY2023, three months to 2023-09-30$697.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure0.9Cost of revenue, Q4 FY2023, three months to 2023-12-31$927.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure0.7Cost of revenue, Q1 FY2024, three months to 2024-03-31$652.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure0.8Cost of revenue, Q2 FY2024, three months to 2024-06-30$778.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure0.8Cost of revenue, Q3 FY2024, three months to 2024-09-30$804.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure0.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$790.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure0.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$760.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure0.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Research and development$m11.9Research and development, Q3 FY2023, three months to 2023-09-30$11.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure12.8Research and development, Q4 FY2023, three months to 2023-12-31$12.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure13.6Research and development, Q1 FY2024, three months to 2024-03-31$13.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure13.1Research and development, Q2 FY2024, three months to 2024-06-30$13.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure10.0Research and development, Q3 FY2024, three months to 2024-09-30$10.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure14.3Research and development, Q4 FY2024, three months to 2024-12-31$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure8.8Research and development, Q1 FY2025, three months to 2025-03-31$8.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure48.8Research and development, Q2 FY2025, three months to 2025-06-30$48.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure14.3Research and development, Q3 FY2025, three months to 2025-09-30$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure19.0Research and development, Q4 FY2025, three months to 2025-12-31$19.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure17.2Research and development, Q1 FY2026, three months to 2026-03-31$17.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure12.9Research and development, Q2 FY2026, three months to 2026-06-30$12.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Selling, general and administrative$m11.2Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$11.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure10.3Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$10.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure10.6Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$10.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure7.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$7.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure7.2Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$7.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure11.1Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$11.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure12.8Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$12.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure5.9Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$5.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure5.2Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$5.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure5.9Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$5.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure6.3Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$6.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure5.2Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$5.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Operating income$m(17.8)Operating income, Q3 FY2023, three months to 2023-09-30−$17.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure(17.7)Operating income, Q4 FY2023, three months to 2023-12-31−$17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure(19.5)Operating income, Q1 FY2024, three months to 2024-03-31−$19.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure(15.6)Operating income, Q2 FY2024, three months to 2024-06-30−$15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure(13.4)Operating income, Q3 FY2024, three months to 2024-09-30−$13.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure(18.9)Operating income, Q4 FY2024, three months to 2024-12-31−$18.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure(15.2)Operating income, Q1 FY2025, three months to 2025-03-31−$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure(54.7)Operating income, Q2 FY2025, three months to 2025-06-30−$54.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure(19.5)Operating income, Q3 FY2025, three months to 2025-09-30−$19.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure(24.9)Operating income, Q4 FY2025, three months to 2025-12-31−$24.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure(23.5)Operating income, Q1 FY2026, three months to 2026-03-31−$23.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure(18.1)Operating income, Q2 FY2026, three months to 2026-06-30−$18.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$58.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-08, accession 0001628280-23-037905.Report this figure0.1Interest expense, Q4 FY2023, three months to 2023-12-31$57.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-13, accession 0001628280-24-010901. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2024, three months to 2024-03-31$58.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-08, accession 0001628280-24-021657.Report this figure0.1Interest expense, Q2 FY2024, three months to 2024-06-30$58.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$38.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-07, accession 0001628280-24-035636.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Net income$m(16.3)Net income, Q3 FY2023, three months to 2023-09-30−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure(16.3)Net income, Q4 FY2023, three months to 2023-12-31−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure(18.3)Net income, Q1 FY2024, three months to 2024-03-31−$18.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure(14.6)Net income, Q2 FY2024, three months to 2024-06-30−$14.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure(12.5)Net income, Q3 FY2024, three months to 2024-09-30−$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure(18.3)Net income, Q4 FY2024, three months to 2024-12-31−$18.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure73.0Net income, Q1 FY2025, three months to 2025-03-31$73.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure(52.6)Net income, Q2 FY2025, three months to 2025-06-30−$52.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure(17.7)Net income, Q3 FY2025, three months to 2025-09-30−$17.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure(23.3)Net income, Q4 FY2025, three months to 2025-12-31−$23.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure(22.2)Net income, Q1 FY2026, three months to 2026-03-31−$22.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure(16.6)Net income, Q2 FY2026, three months to 2026-06-30−$16.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Diluted EPS$ per share(0.60)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figurenot reported(0.68)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure(0.54)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure(0.46)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figurenot reported1.83Diluted EPS, Q1 FY2025, three months to 2025-03-31$1.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure(0.76)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure(0.26)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figurenot reported(0.32)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure(0.20)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Basic EPS$ per share(0.60)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figurenot reported(0.68)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure(0.54)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure(0.46)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figurenot reported1.84Basic EPS, Q1 FY2025, three months to 2025-03-31$1.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure(0.76)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure(0.26)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figurenot reported(0.32)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure(0.20)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure

Balance sheet

Cash and equivalents$85.2m, Q2 FY2026
Shareholders' equity$182.9m, Q2 FY2026
Whitehawk Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m68.8Cash and equivalents, Q3 FY2023, at 2023-09-30$68.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-08, accession 0001628280-23-037905.Report this figure62.9Cash and equivalents, FY2023, at 2023-12-31$62.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-28, accession 0001628280-25-015269.Report this figure53.8Cash and equivalents, Q1 FY2024, at 2024-03-31$53.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001628280-24-021657.Report this figure41.1Cash and equivalents, Q2 FY2024, at 2024-06-30$41.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0001628280-24-035636.Report this figure30.5Cash and equivalents, Q3 FY2024, at 2024-09-30$30.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure28.7Cash and equivalents, FY2024, at 2024-12-31$28.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001193125-26-104158.Report this figure228Cash and equivalents, Q1 FY2025, at 2025-03-31$227.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure145Cash and equivalents, Q2 FY2025, at 2025-06-30$144.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure37.9Cash and equivalents, Q3 FY2025, at 2025-09-30$37.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure37.6Cash and equivalents, FY2025, at 2025-12-31$37.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure34.8Cash and equivalents, Q1 FY2026, at 2026-03-31$34.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure85.2Cash and equivalents, Q2 FY2026, at 2026-06-30$85.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Current assets$m133Current assets, Q3 FY2023, at 2023-09-30$132.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037905.Report this figure125Current assets, FY2023, at 2023-12-31$124.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-28, accession 0001628280-25-015269.Report this figure103Current assets, Q1 FY2024, at 2024-03-31$102.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001628280-24-021657.Report this figure93.0Current assets, Q2 FY2024, at 2024-06-30$93.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001628280-24-035636.Report this figure77.3Current assets, Q3 FY2024, at 2024-09-30$77.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure61.3Current assets, FY2024, at 2024-12-31$61.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104158.Report this figure233Current assets, Q1 FY2025, at 2025-03-31$232.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure179Current assets, Q2 FY2025, at 2025-06-30$178.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure165Current assets, Q3 FY2025, at 2025-09-30$165.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure149Current assets, FY2025, at 2025-12-31$149.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure126Current assets, Q1 FY2026, at 2026-03-31$125.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure192Current assets, Q2 FY2026, at 2026-06-30$192.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Total assets$m140Total assets, Q3 FY2023, at 2023-09-30$139.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-08, accession 0001628280-23-037905.Report this figure132Total assets, FY2023, at 2023-12-31$132.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-28, accession 0001628280-25-015269.Report this figure111Total assets, Q1 FY2024, at 2024-03-31$111.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001628280-24-021657.Report this figure102Total assets, Q2 FY2024, at 2024-06-30$101.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001628280-24-035636.Report this figure85.7Total assets, Q3 FY2024, at 2024-09-30$85.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure70.3Total assets, FY2024, at 2024-12-31$70.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001193125-26-104158.Report this figure234Total assets, Q1 FY2025, at 2025-03-31$234.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure181Total assets, Q2 FY2025, at 2025-06-30$180.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure167Total assets, Q3 FY2025, at 2025-09-30$167.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure151Total assets, FY2025, at 2025-12-31$150.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure127Total assets, Q1 FY2026, at 2026-03-31$127.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure194Total assets, Q2 FY2026, at 2026-06-30$194.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Current liabilities$m20.5Current liabilities, Q3 FY2023, at 2023-09-30$20.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-08, accession 0001628280-23-037905.Report this figure26.4Current liabilities, FY2023, at 2023-12-31$26.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-28, accession 0001628280-25-015269.Report this figure19.9Current liabilities, Q1 FY2024, at 2024-03-31$19.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001628280-24-021657.Report this figure22.1Current liabilities, Q2 FY2024, at 2024-06-30$22.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001628280-24-035636.Report this figure15.8Current liabilities, Q3 FY2024, at 2024-09-30$15.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure17.1Current liabilities, FY2024, at 2024-12-31$17.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104158.Report this figure12.3Current liabilities, Q1 FY2025, at 2025-03-31$12.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure8.8Current liabilities, Q2 FY2025, at 2025-06-30$8.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure9.8Current liabilities, Q3 FY2025, at 2025-09-30$9.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure14.5Current liabilities, FY2025, at 2025-12-31$14.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure11.1Current liabilities, Q1 FY2026, at 2026-03-31$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure11.1Current liabilities, Q2 FY2026, at 2026-06-30$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Total liabilities$m21.5Total liabilities, Q3 FY2023, at 2023-09-30$21.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-08, accession 0001628280-23-037905.Report this figure27.2Total liabilities, FY2023, at 2023-12-31$27.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-28, accession 0001628280-25-015269.Report this figure20.6Total liabilities, Q1 FY2024, at 2024-03-31$20.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0001628280-24-021657.Report this figure22.8Total liabilities, Q2 FY2024, at 2024-06-30$22.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0001628280-24-035636.Report this figure16.8Total liabilities, Q3 FY2024, at 2024-09-30$16.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure17.8Total liabilities, FY2024, at 2024-12-31$17.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001193125-26-104158.Report this figure12.3Total liabilities, Q1 FY2025, at 2025-03-31$12.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure8.8Total liabilities, Q2 FY2025, at 2025-06-30$8.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure9.8Total liabilities, Q3 FY2025, at 2025-09-30$9.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure14.5Total liabilities, FY2025, at 2025-12-31$14.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure11.1Total liabilities, Q1 FY2026, at 2026-03-31$11.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure11.1Total liabilities, Q2 FY2026, at 2026-06-30$11.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure
Shareholders' equity$m118Shareholders' equity, Q3 FY2023, at 2023-09-30$118.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure105Shareholders' equity, FY2023, at 2023-12-31$105.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001193125-26-104158.Report this figure90.5Shareholders' equity, Q1 FY2024, at 2024-03-31$90.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure78.8Shareholders' equity, Q2 FY2024, at 2024-06-30$78.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure68.9Shareholders' equity, Q3 FY2024, at 2024-09-30$68.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure52.5Shareholders' equity, FY2024, at 2024-12-31$52.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure222Shareholders' equity, Q1 FY2025, at 2025-03-31$221.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure172Shareholders' equity, Q2 FY2025, at 2025-06-30$172.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure157Shareholders' equity, Q3 FY2025, at 2025-09-30$157.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure136Shareholders' equity, FY2025, at 2025-12-31$136.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure116Shareholders' equity, Q1 FY2026, at 2026-03-31$116.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure183Shareholders' equity, Q2 FY2026, at 2026-06-30$182.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure

Cash flow

Operating cash flow−$14.5m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Whitehawk Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(12.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001628280-24-045698. Derived: 9-month figure less the 6-month figure.Report this figure(9.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure(19.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure(9.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-105081. Derived: 6-month figure less the 3-month figure.Report this figure(15.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268895. Derived: 9-month figure less the 6-month figure.Report this figure(15.1)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$15.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure(11.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$11.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure(53.0)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$53.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337933. Derived: 6-month figure less the 3-month figure.Report this figure(15.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$15.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268895. Derived: 9-month figure less the 6-month figure.Report this figure(17.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$17.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure(22.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$22.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure(14.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337933. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001628280-24-045698. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2023, three months to 2023-12-31$816.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-28, accession 0001628280-25-015269. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2024, three months to 2024-03-31$739.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure0.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$541.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-105081. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$188.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268895. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$186.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$551.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337933. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268895. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104158. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337933. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)82.89m, Q2 FY2026
Whitehawk Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares21.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3021,269,163 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-08, accession 0001628280-23-037905.Report this figure26.9Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3126,862,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-08, accession 0001628280-24-021657.Report this figure26.9Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3026,879,089 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0001628280-24-035636.Report this figure26.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3026,946,683 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001628280-24-045698.Report this figure27.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3126,980,698 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0001628280-25-023932.Report this figure27.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3027,010,013 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0000950170-25-105081.Report this figure27.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3027,041,327 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure39.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3139,932,539 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure69.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3069,083,127 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure69.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3069,204,899 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268895.Report this figure69.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3169,236,945 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-212075.Report this figure82.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3082,886,196 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure

Shares outstanding: 57.01mShares outstanding, period not labelled, at 2026-08-0357,009,010 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-337933.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.